Our Technology

Saranas has developed a technology that allows for the early detection and monitoring of bleeding complications associated with vascular access procedures.

The Early Bird Bleed Monitoring System includes a vascular access sheath with embedded sensors that measure the electrical resistance across the blood vessel. By sensing a change in the vessel’s electrical resistance, the Early Bird is designed to detect and monitor bleeding from a blood vessel accidentally injured during endovascular procedures, such as transcatheter aortic valve replacement, large bore hemodynamic support device placement, or other complex endovascular interventions, where the femoral artery or vein is used to gain vascular access. The technology was invented at the Texas Heart Institute.

Our Technology

Saranas has developed a technology that allows for the early detection and monitoring of bleeding complications associated with vascular access procedures.

The Early Bird Bleed Monitoring System includes a vascular access sheath with embedded sensors that measure the electrical resistance across the blood vessel. By sensing a change in the vessel’s electrical resistance, the Early Bird is designed to detect and monitor bleeding from a blood vessel accidentally injured during endovascular procedures, such as transcatheter aortic valve replacement, large bore hemodynamic support device placement, or other complex cardiac interventions, where the femoral artery or vein is used to gain vascular access. The technology was invented at the Texas Heart Institute.

WHY THE NEED FOR EARLY BLEED DETECTION

Rapid detection of internal bleeding complications with the Early Bird may enable physicians to mitigate downstream consequences by addressing bleeding complications immediately, improving patient outcomes and lowering healthcare costs.

BLEEDING IS FREQUENT

over 20 Million patients

Each year, over 20 million patients in the US require access to a blood vessel for the non-surgical procedures known as vascular access procedures.

Approximately 1 million of these patients experience a severe bleeding complication, resulting in significant additional healthcare expenditures and placing the patient at an increased risk of death.

Changing Reimbursement Landscape

Currently there is no cost effective technology that can alert clinicians early enough to prevent bleeding complications from becoming a life-threatening and expensive emergency. With healthcare costs under increasing public scrutiny, hospitals are unlikely to receive additional reimbursement for these procedures.

Starting 2015, 25% of all hospitals with the highest incidence of medical complications will lose 1% of their entire Medicare reimbursement (an estimated $1.7 billion nationwide). Total direct and indirect costs of internal bleeding complications are estimated to be $8.4 billion.

Cost per Complication: Total of $13,000

Early detection will avoid most downstream costs listed

Literature Review of vascular Complication Rates

Saranas’ target procedures each involve most of these risk factors

BLEEDING ADDS TREMENDOUS COST

+$18,000 PER EVENT

Redfors B et al. JAMA Cardiol. 2017; 2 (7) 798-802.

Redfors B et al. JAMA Cardiol. 2017;2(7):798-802

*This product currently is not for sale in the US, EU or Canada.​ ​However, we are working with regulatory agencies to make ​t​he Saranas ​s​ystem available around the world!